8-K/A: Avanos Medical Appoints David Pacitti as New CEO, Effective April 14, 2025

Avanos Medical names David Pacitti as its new Chief Executive Officer, effective April 14, 2025, with a compensation package including a base salary, bonus potential, and significant equity awards.

Summary

• Avanos Medical, Inc. announced the appointment of David Pacitti as the company's Chief Executive Officer, effective April 14, 2025.
• Mr. Pacitti joins Avanos from Siemens Healthineers, where he served as President and Head of the Americas.
• His compensation includes a base salary of $1,050,000 per year and eligibility for an annual cash incentive program with a bonus target of 110% of his base salary.
• He is also eligible for annual long-term incentive grants with a target award value for 2026 of $5,000,000.
• Mr. Pacitti will receive a one-time equity award of performance-based restricted share units (PRSUs) with an award value equal to $3,500,000, vesting on the third anniversary of the grant date based on stock price performance.
• He will also receive a one-time equity award of time-based restricted share units (TRSUs) with an award value equal to $3,500,000, vesting over three years.
• Additionally, Mr. Pacitti will receive a one-time $500,000 cash payment within 30 days of his start date.
• Michael C. Greiner will continue to serve as Interim Chief Executive Officer until Mr. Pacitti's commencement.

Sentiment

Score: 7

Explanation: The announcement is generally positive due to the appointment of a new CEO with a strong background. The compensation package is substantial and includes performance-based incentives, which is a good sign. However, the success of the new CEO is not guaranteed, and there are risks associated with achieving the stock price targets for the PRSUs.

Positives

• The appointment of an experienced executive like David Pacitti from Siemens Healthineers could bring fresh perspectives and leadership to Avanos Medical.
• The compensation package, including performance-based equity awards, aligns Mr. Pacitti's interests with those of the shareholders.
• The one-time cash payment and equity awards provide a strong incentive for Mr. Pacitti to drive growth and improve the company's performance.

Risks

• The vesting of PRSUs is contingent on the company's stock price reaching certain targets, which may not be achieved.
• The success of Mr. Pacitti in his new role is not guaranteed and depends on various factors, including market conditions and his ability to execute the company's strategy.

Future Outlook

The company expects Michael C. Greiner to continue serving as Interim CEO until David Pacitti commences his service on April 14, 2025.

Industry Context

The appointment of a seasoned executive from a major healthcare technology company like Siemens Healthineers suggests Avanos Medical is looking to strengthen its position in the medical device market and potentially pursue new growth opportunities.

Comparison to Industry Standards

• CEO compensation packages in the medical device industry vary widely depending on company size, performance, and the executive's experience.
• Base salaries for CEOs of companies similar in size to Avanos Medical typically range from $800,000 to $1.5 million.
• Equity awards are a common component of CEO compensation packages, often tied to performance metrics such as revenue growth, profitability, and stock price appreciation.
• The performance-based vesting of Mr. Pacitti's PRSUs aligns with industry best practices for incentivizing executives to achieve specific financial goals.
• Comparing Avanos Medical's CEO compensation structure to that of competitors like Medtronic, Boston Scientific, and Stryker would provide further context.

Management Changes

Stakeholder Impact

• Shareholders may react positively to the appointment of a new CEO with a strong track record.
• Employees may experience changes in leadership and strategy under the new CEO.
• Customers and suppliers may see changes in the company's products, services, and relationships.

Key Dates

Keywords

CEO, David Pacitti, Avanos Medical, Appointment, Compensation, Executive, Siemens Healthineers